Evidence map›Paper›PMID 34661340›Full record

ArticleMolecular nutrition & food research2021

Food and Microbiota Metabolites Associate with Cognitive Decline in Older Subjects: A 12-Year Prospective Study.

Raúl González-Domínguez, Pol Castellano-Escuder, Francisco Carmona, Sophie Lefèvre-Arbogast, Dorrain Y Low, Andrea Du Preez, Silvie R Ruigrok, Claudine Manach, Mireia Urpi-Sarda, Aniko Korosi and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Re-evaluation of acesulfame K (E 950) as food additive.EFSA journal. European Food Safety Authority · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. QCAnalytical chemistry · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Raúl González-DomínguezBiomarkers and Nutrimetabolomics Laboratory, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0002-7640-8833
Pol Castellano-EscuderBiomarkers and Nutrimetabolomics Laboratory, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, 08028, Spain.
Francisco CarmonaCIBER Fragilidad y Envejecimiento Saludable (CIBERfes), Instituto de Salud Carlos III, Madrid, 28029, Spain.
Sophie Lefèvre-ArbogastUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, F-33000, France.
Dorrain Y LowUniversité Clermont Auvergne, INRAE, UNH, Clermont, Ferrand, F-63000, France.
Andrea Du PreezDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.
Silvie R RuigrokBrain Plasticity Group, Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, 1098 XH, The Netherlands.
Claudine ManachUniversité Clermont Auvergne, INRAE, UNH, Clermont, Ferrand, F-63000, France.
Mireia Urpi-SardaBiomarkers and Nutrimetabolomics Laboratory, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, 08028, Spain.
Aniko KorosiBrain Plasticity Group, Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, 1098 XH, The Netherlands.ORCID 0000-0001-9701-3331
Paul J LucassenBrain Plasticity Group, Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, 1098 XH, The Netherlands.
Ludwig AignerInstitute of Molecular Regenerative Medicine, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University, Salzburg, 5020, Austria.
Mercè PallàsPharmacology Section, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, Barcelona, 08028, Spain.
Sandrine ThuretDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.
Cécilia SamieriUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, F-33000, France.
Alex Sánchez-PlaCIBER Fragilidad y Envejecimiento Saludable (CIBERfes), Instituto de Salud Carlos III, Madrid, 28029, Spain.
Cristina Andres-LacuevaBiomarkers and Nutrimetabolomics Laboratory, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0002-8494-4978
Instituto de Salud Carlos III · ESNetherlands Institute for Neuroscience · NLKing's College London · GBUniversité Clermont Auvergne · FRUniversité de Bordeaux · FRParacelsus Medical University · ATUniversitat de Barcelona · ES

Funding

Medical Research Council MR/S00484X/1Medical Research Council UK MR/N030087/1
6 · The paper itself

Abstract

scopeDiet is considered an important modulator of cognitive decline and dementia, but the available evidence is, however, still fragmented and often inconsistent. METHODS AND

resultsThe article studies the long-term prospective Three-City Cohort, which consists of two separate nested case-control sample sets from different geographic regions (Bordeaux, n = 418; Dijon, n = 424). Cognitive decline is evaluated through five neuropsychological tests (Mini-Mental State Examination, Benton Visual Retention Test, Isaac's Set Test, Trail-Making Test part A, and Trail-Making Test part B). The food-related and microbiota-derived circulating metabolome is studied in participants free of dementia at baseline, by subjecting serum samples to large-scale quantitative metabolomics analysis. A protective association is found between metabolites derived from cocoa, coffee, mushrooms, red wine, the microbial metabolism of polyphenol-rich foods, and cognitive decline, as well as a negative association with metabolites related to unhealthy dietary components, such as artificial sweeteners and alcohol.

conclusionThese results provide insight into the early metabolic events that are associated with the later risk to develop cognitive decline within the crosstalk between diet, gut microbiota and the endogenous metabolism, which can help identify potential targets for preventive and therapeutic strategies to preserve cognitive health.

Indexed as

Cognitive DysfunctionGastrointestinal MicrobiomeMicrobiotaAgedFoodHumansProspective Studiescognitive declinedietfood metabolomegut microbiotametabolomics

Identifiers

PMID34661340
PMCPMC11475530
OpenAlexW3207731039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.